Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
InnoCare Pharma a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase b clinical study of the combination of InnoCares
IASO Bio a biopharmaceutical company engaged in discovering developing manufacturing and marketing innovative cell therapies and antibody products today announced that China National Medical Products
On March th the US FDA granted approval for Mercks WINREVAIR sotaterceptcsrk marking a significant milestone in pulmonary arterial hypertension PAH treatment PAH characterized by elevated blood pressure in the arteries connecting the heart and lungs...
Biocon Limited an innovationled global biopharmaceuticals company announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency UK for its complex formulation
ANI Pharmaceuticals Inc today announced the launch of Levofloxacin Oral Solution a generic version of the Reference Listed Drug Levaquin The current annual US market for Levofloxacin Oral Solution is approximately million according to latest estimat...
Oncopeptides AB a biotech company focused on difficulttotreat cancers and Vector Pharma FZCO today announced a collaboration to commercialize Oncopeptides flagship drug Pepaxti
Santhera Pharmaceuticals announces that the China National Medical Products Administration has accepted for priority review the new drug application for vamorolone
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and
TiumBio Co Ltd a clinicalstage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable diseases has announced the filing of a Clinical
Bridge Biotherapeutics a South Korean clinicalstage biotech company developing novel drugs for cancer
